Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

184
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
184
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

376
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
376
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

179
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
179
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

176
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
176
Drug Elimination by Renal Route: Tubular Reabsorption01:22

Drug Elimination by Renal Route: Tubular Reabsorption

3.4K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
3.4K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

412
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
412

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Current views on sustainability in urology: findings from the North Central Section of American Urological Association membership survey.

Frontiers in urology·2026
Same author

Development and validation of an LC-MS/MS method for measurement of porphobilinogen in urine.

Clinica chimica acta; international journal of clinical chemistry·2025
Same author

Instrument Multiplexing: Amplified Throughput for Measurement of Vitamin B1 in Whole Blood Using Parallel Liquid Chromatography Systems Interfaced to a Single Mass Spectrometer.

Clinical chemistry·2025
Same author

Analysis of Urinary Metanephrines Using Liquid Chromatography Tandem Mass Spectrometry.

Methods in molecular biology (Clifton, N.J.)·2025
Same author

A rare case of fibromuscular dysplasia involving the cervicocephalic arterial tree highlighting the neuropathological findings.

Journal of neuropathology and experimental neurology·2024
Same author

Best Practices for Reducing Bias in the Interview Process.

Current urology reports·2022
Same journal

Canaliculitis associated with multiple retained silicone punctal plugs and concurrent biodegradable plug placement.

BMJ case reports·2026
Same journal

Bilateral vocal cord paralysis in multifocal motor neuropathy.

BMJ case reports·2026
Same journal

Multiple visceral artery aneurysms and type II Abernethy malformation in a patient with autoimmune hepatitis.

BMJ case reports·2026
Same journal

Congenital nasolacrimal duct cyst complicating as an orbital abscess.

BMJ case reports·2026
Same journal

Management of <i>Achromobacter xylosoxidans</i> bacteraemia with an atypical antimicrobial resistance pattern.

BMJ case reports·2026
Same journal

Unintentional chronic acetaminophen overuse as an under-recognised cause of liver injury.

BMJ case reports·2026
查看所有相关文章

相关实验视频

Updated: Jul 7, 2025

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
07:45

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis

Published on: February 9, 2021

3.6K

费尔巴酸盐的 urolithiasis 的发生.

Ilana Bergelson1, Chance Walker2,3, Elizabeth L Frank3,4

  • 1Department of Urology, The University of Iowa Hospitals and Clinics, Iowa City, lowa, USA ilana-bergelson@uiowa.edu.

BMJ case reports
|December 21, 2023
PubMed
概括
此摘要是机器生成的。

药物诱导的甲是多种药物治疗患者的风险. 这一案例突出了成年人的石,强调了石头分析和神经科医生和泌尿科医生之间的沟通的必要性.

关键词:
和发作,以及发作.泌尿外科手术是什么意思

更多相关视频

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor
05:54

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor

Published on: December 13, 2017

14.0K
Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
08:42

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport

Published on: November 27, 2016

11.2K

相关实验视频

Last Updated: Jul 7, 2025

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
07:45

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis

Published on: February 9, 2021

3.6K
MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor
05:54

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor

Published on: December 13, 2017

14.0K
Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
08:42

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport

Published on: November 27, 2016

11.2K

科学领域:

  • 腎臟病學 (nephrology) 是一種醫學專業.
  • 药理学 药理学是指药理学的学科.
  • 神经学 神经学

背景情况:

  • 药物诱导的结石是重复结石和多药物治疗的患者的一个重大问题.
  • 费尔巴酸甲病已在儿科患者中记录,但很少在成年人中出现.

研究的目的:

  • 报告已知最古老的费尔巴酸甲状腺瘤病例,发生在成人患者身上.
  • 强调石头分析和跨学科沟通在治疗药物诱导结石方面的重要性.

主要方法:

  • 一个30多岁的成年男性患有莱诺克斯-加斯托综合征的病例报告.
  • 对临床表现,药物史 (felbamate) 和石头分析的审查.

主要成果:

  • 尽管患者服用了适度剂量,但患者患上了felbamate石头,这表明药物血清水平可能很高.
  • 石头分析对于识别与药物相关的石头至关重要,特别是当结果不确定且没有感染时.

结论:

  • 费尔巴酸盐结石可以发生在成年患者身上,即使使用标准剂量.
  • 泌尿科医生必须对药物诱导的结石保持高度怀疑,并与神经科医生合作,以防止其复发.